A new small molecule inhibitor of soluble guanylate cyclase.

about

Inhibition of soluble guanylyl cyclase by small molecules targeting the catalytic domain Facile, eco-friendly, catalyst-free synthesis of polyfunctionalized quinoxalines.Structure/function of the soluble guanylyl cyclase catalytic domain.

P2860

Q42380504-BE290A33-1921-4DA0-8FC1-B3C220009721 Q47600003-BB580028-4DD0-4AB1-A045-6BF60BFE3443 Q55436230-F37C83F0-8422-4026-A53B-24CE29B1AE95

P2860

A new small molecule inhibitor of soluble guanylate cyclase.

Item

http://www.wikidata.org/entity/Q35743176

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A new small molecule inhibitor of soluble guanylate cyclase.

@ast

A new small molecule inhibitor of soluble guanylate cyclase.

@en

type

Item

label

A new small molecule inhibitor of soluble guanylate cyclase.

@ast

A new small molecule inhibitor of soluble guanylate cyclase.

@en

prefLabel

A new small molecule inhibitor of soluble guanylate cyclase.

@ast

A new small molecule inhibitor of soluble guanylate cyclase.

@en

P1476

A new small molecule inhibitor of soluble guanylate cyclase.

@en

P2093

Charles K Allerston

http://www.w3.org/2001/XMLSchema#string

John Garthwaite

http://www.w3.org/2001/XMLSchema#string

Kathryn Hampden-Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism

Crystal structures of the catalytic domain of human soluble guanylate cyclase

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.

Structural determinants of natriuretic peptide receptor specificity and degeneracy

Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation.

NO-independent regulatory site on soluble guanylate cyclase.

Synopsis of some recent tactical application of bioisosteres in drug design.

Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses

Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.

P304

5303-5310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMC.2015.07.074

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul G Gane

Filipa Mota

David L Selwood

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280997237

http://www.w3.org/2001/XMLSchema#string

P698

26264842

http://www.w3.org/2001/XMLSchema#string

P932

4558462

http://www.w3.org/2001/XMLSchema#string

A new small molecule inhibitor of soluble guanylate cyclase.

about

P2860

P2860

A new small molecule inhibitor of soluble guanylate cyclase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932